Stoyanka Nikolova

641 total citations
48 papers, 460 citations indexed

About

Stoyanka Nikolova is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Stoyanka Nikolova has authored 48 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Stoyanka Nikolova's work include Synthesis and Biological Activity (9 papers), Chemical synthesis and alkaloids (8 papers) and Synthesis and biological activity (6 papers). Stoyanka Nikolova is often cited by papers focused on Synthesis and Biological Activity (9 papers), Chemical synthesis and alkaloids (8 papers) and Synthesis and biological activity (6 papers). Stoyanka Nikolova collaborates with scholars based in Bulgaria, Iran and India. Stoyanka Nikolova's co-authors include Iliyan Ivanov, Manjunath Ghate, Mehran Feizi‐Dehnayebi, Iliyana Stefanova, Mina Todorova, Ghodsi Mohammadi Ziarani, Yulian Tumbarski, Paraskev Nedialkov, Rositsa Mihaylova and Plamen Zagorchev and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Stoyanka Nikolova

40 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stoyanka Nikolova Bulgaria 12 273 111 68 63 44 48 460
Maité Sylla‐Iyarreta Veitía France 13 319 1.2× 143 1.3× 30 0.4× 40 0.6× 29 0.7× 31 575
Krishnendu Bera India 16 526 1.9× 262 2.4× 55 0.8× 72 1.1× 53 1.2× 28 793
Л. В. Аникина Russia 15 466 1.7× 197 1.8× 44 0.6× 47 0.7× 25 0.6× 75 663
Wouter Bakker Netherlands 12 276 1.0× 133 1.2× 63 0.9× 35 0.6× 36 0.8× 34 456
Pavel Bobáľ Czechia 15 337 1.2× 266 2.4× 39 0.6× 38 0.6× 32 0.7× 49 651
Yu‐Hang Miao China 14 411 1.5× 95 0.9× 52 0.8× 19 0.3× 63 1.4× 28 618
Xun Ji China 16 419 1.5× 212 1.9× 21 0.3× 78 1.2× 74 1.7× 29 650
Nuran Kahriman Türkiye 14 214 0.8× 105 0.9× 123 1.8× 17 0.3× 28 0.6× 42 451
Rodrigo Said Razo‐Hernández Mexico 13 216 0.8× 126 1.1× 18 0.3× 35 0.6× 31 0.7× 44 382
María Inés Nicolás‐Vázquez Mexico 13 143 0.5× 109 1.0× 73 1.1× 25 0.4× 11 0.3× 50 488

Countries citing papers authored by Stoyanka Nikolova

Since Specialization
Citations

This map shows the geographic impact of Stoyanka Nikolova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stoyanka Nikolova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stoyanka Nikolova more than expected).

Fields of papers citing papers by Stoyanka Nikolova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stoyanka Nikolova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stoyanka Nikolova. The network helps show where Stoyanka Nikolova may publish in the future.

Co-authorship network of co-authors of Stoyanka Nikolova

This figure shows the co-authorship network connecting the top 25 collaborators of Stoyanka Nikolova. A scholar is included among the top collaborators of Stoyanka Nikolova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stoyanka Nikolova. Stoyanka Nikolova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todorova, Mina, Silvia Angelova, Iliyana Stefanova, et al.. (2025). Silver Nanoparticles with Mebeverine in IBS Treatment: DFT Analysis, Spasmolytic, and Anti-Inflammatory Effects. Pharmaceutics. 17(5). 561–561.
2.
3.
Todorova, Mina, et al.. (2025). Echinops as a Source of Bioactive Compounds—A Systematic Review. Pharmaceuticals. 18(9). 1353–1353.
4.
Todorova, Mina, Silvia Angelova, Iliyana Stefanova, et al.. (2025). Functionalized Silver Nanoparticles as Multifunctional Agents Against Gut Microbiota Imbalance and Inflammation. Nanomaterials. 15(11). 815–815.
5.
Todorova, Mina, Ivayla Dincheva, Daniela Batovska, et al.. (2025). Metabolite Signatures and Particle Size as Determinants of Anti-Inflammatory and Gastrointestinal Smooth Muscle Modulation by Chlorella vulgaris. Foods. 14(19). 3319–3319.
6.
Todorova, Mina, Dimitar N. Petrov, Zhana Petkova, et al.. (2025). From Spirulina platensis to Nanomaterials: A Comparative Study of AgNPs Obtained from Two Extracts. Nanomaterials. 15(18). 1392–1392. 1 indexed citations
7.
Tumbarski, Yulian, Ivan Ivanov, Mina Todorova, et al.. (2025). Metabolic Profile, Antioxidant, Antimicrobial, Contractile, and Anti-Inflammatory Potential of Moringa oleifera Leaves (India). Life. 15(4). 583–583. 1 indexed citations
8.
Stefanova, Iliyana, et al.. (2024). Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine Derivatives. Biomedicines. 12(10). 2321–2321. 3 indexed citations
9.
Nikolova, Stoyanka, et al.. (2024). Therapeutic Potential of 1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline. Molecules. 29(16). 3804–3804. 1 indexed citations
10.
Ziarani, Ghodsi Mohammadi, et al.. (2024). Fumed-Si-Pr-Ald-Barb as a Fluorescent Chemosensor for the Hg2+ Detection and Cr2O72− Ions: A Combined Experimental and Computational Perspective. Molecules. 29(20). 4825–4825. 39 indexed citations
11.
Andonova, Velichka, et al.. (2024). Spectral Characteristics, In Silico Perspectives, Density Functional Theory (DFT), and Therapeutic Potential of Green-Extracted Phycocyanin from Spirulina. International Journal of Molecular Sciences. 25(17). 9170–9170. 14 indexed citations
12.
Todorova, Mina, et al.. (2023). Drug-Loaded Silver Nanoparticles—A Tool for Delivery of a Mebeverine Precursor in Inflammatory Bowel Diseases Treatment. Biomedicines. 11(6). 1593–1593. 14 indexed citations
13.
Stefanova, Iliyana, Rositsa Mihaylova, Yulian Tumbarski, et al.. (2023). In Silico, In Vitro, and Ex Vivo Biological Activity of Some Novel Mebeverine Precursors. Biomedicines. 11(2). 605–605. 8 indexed citations
14.
Nikolova, Stoyanka, et al.. (2023). Synthesis of N-[1-(2-Acetyl-4,5-dimethoxyphenyl)propan-2-yl]benzamide and Its Copper(II) Complex. Russian Journal of General Chemistry. 93(1). 161–165. 1 indexed citations
15.
Nikolova, Stoyanka, Mehran Feizi‐Dehnayebi, Vassil B. Delchev, et al.. (2023). Drug-Delivery Silver Nanoparticles: A New Perspective for Phenindione as an Anticoagulant. Biomedicines. 11(8). 2201–2201. 33 indexed citations
16.
Stefanova, Iliyana, et al.. (2023). 1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline. SHILAP Revista de lepidopterología. 2023(2). M1608–M1608. 1 indexed citations
17.
Nikolova, Stoyanka, et al.. (2022). N-(2-Benzoyl-4,5-dimethoxyphenethyl)-2-phenylacetamide. SHILAP Revista de lepidopterología. 2022(2). M1376–M1376. 1 indexed citations
18.
Nikolova, Stoyanka, et al.. (2022). Ability of 2-Chloro-N-(1-(3,4-dimethoxyphenyl)propan-2-yl)-2-phenylacetamide to Stimulate Endogenous Nitric Oxide Synthesis. Applied Sciences. 12(9). 4473–4473. 3 indexed citations
19.
Nikolova, Stoyanka, et al.. (2022). Ex Vivo and In Vivo Study of Some Isoquinoline Precursors. Scientia Pharmaceutica. 90(2). 37–37. 9 indexed citations
20.
Nikolova, Stoyanka. (2011). Genetic variability of local Bulgarian honey bees Apis mellifera macedonica (rodopica) based on microsatellite DNA analysis. Journal of Apicultural Science. 55(2). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maité Sylla‐Iyarreta Veitía Breakdown of academic impact, for papers by Krishnendu Bera Breakdown of academic impact, for papers by Л. В. Аникина Breakdown of academic impact, for papers by Wouter Bakker Breakdown of academic impact, for papers by Pavel Bobáľ Breakdown of academic impact, for papers by Yu‐Hang Miao Breakdown of academic impact, for papers by Xun Ji Breakdown of academic impact, for papers by Nuran Kahriman Breakdown of academic impact, for papers by Rodrigo Said Razo‐Hernández Breakdown of academic impact, for papers by María Inés Nicolás‐Vázquez
Rankless by CCL
2026